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Dear Editor,
Biomarkers represent an essential tool for identifi-
cation of patients developing infection and to deter-
mine their clinical severity. Procalcitonin (PCT)
levels appeared to be correlated with the develop-
ment of severe bacterial infections [1]. Thus, PCT
systematic use has been proposed as part of the
diagnostic tools and for monitoring treatment dur-
ation [2, 3], but not all of the potential benefits and
limitations of PCT have been investigated.
We retrospectively performed a case-control study
analyzing all patients with positive blood cultures
(BCs) in the period of January 2017 to December
2017 at a 1100-bed teaching hospital in Italy and
investigating the correlation between PCT and
C-reactive protein (CRP) values (± 24 h from BC col-
lection) in pathogens causing bloodstream infections.
The study flowchart is presented in Additional file 1:
Figure S1. During the study period, 1296 positive BCs
were retrieved; of these, 258 (19.9%) episodes were
recorded in the intensive care unit (ICU) and were
included in the study. Moreover, 213 patients hospi-
talized in ICU with negative BC were used as control.
Finally, 471 ICU patients were analyzed. Clinical charac-
teristic and outcome of patients, according to BC results,
are reported in Additional file 1: Table S1. As reported in
Fig. 1, PCT concentrations (in nanograms per milliliter)
were 25.1 ± 19.9 in patients with Gram-negative (GN)
etiology, 29.9 ± 13.2 for Enterobacteriaceae, 8.9 ± 7.5 for
Gram-positive (GP), and 2.1 ± 1.8 for fungi. Finally, in
Additional file 1: Figure S1, receiver operating characteris-
tic curves showed an area under the curve of 0.7 (95%
confidence interval (CI) 0.62–0.77, P < 0.001) for PCT and
0.45 (95% CI 0.37–0.54, P = 0.32) for CRP among GN iso-
lates, 0.74 (95% CI 0.67–0.81, P <0.001) for PCT and 0.49
(95% CI 0.4–0.57, P = 0.82) for CRP among Enterobacteri-
aceae, 0.46 (95% CI 0.39–0.53, P = 0.38) for PCT and 0.41
(95% CI 0.33–0.48, P = 0.01) for CRP among GP isolates,
and 0.64 (95% CI 0.46–0.83, P = 0.22) for PCT and
0.59 (95% CI 0.45–0.73, P = 0.43) for CRP among
fungi. Finally, logistic regression analysis showed that
PCT values of more than 0.5 ng/mL and more than
10 ng/mL were independently associated with BCs
positive for Enterobacteriaceae.
Our data confirmed the previous observations
about the role of PCT and CRP in predicting BC re-
sults in critically ill patients [4, 5]. Of interest, CRP
was not able to predict BC results, whereas PCT
values correlated with GN bacteremia and, among
them, specifically identified Enterobacteriaceae. High
PCT values (> 10 ng/mL) were independently associ-
ated with Enterobacteriaceae isolation. Even with
the limitation of a single-center experience, these
results might be useful to determine another role
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for PCT, helping physicians in the rapid identifica-
tion of bacteremic ICU patients at risk of GN infec-
tion (especially Enterobacteriaceae) and driving the
choice of a more appropriate empirical therapy.
Additional file
Additional file 1: Figure S1. Receiver operating characteristic curves
about procalcitonin (PCT) and C-reactive protein (CRP) to predict
blood cultures positive for Gram-negative (A), Enterobacteriaceae (B),
Gram-positive (C), and fungal (D) etiology. Table S1. Clinical characteristics
and outcome of patients according to etiology of infection. COPD chronic
obstructive pulmonary disease, CRP C-reactive protein, CVC central venous
catheter, ICU intensive care unit, ns not significant, PCT procalcitonin, SAPS
simplified acute physiology score, SD standard deviation, SSTI skin and soft
tissue infection. *Gram-positive etiology versus Gram-negative etiology.
#Gram-negative etiology versus fungal etiology. §Gram-positive etiology
versus fungal etiology. (DOC 435 kb)
Abbreviations
BC: Blood culture; CI: Confidence interval; CRP: C-reactive protein;
GN: Gram-negative; GP: Gram-positive; ICU: Intensive care unit;
PCT: Procalcitonin
Availability of data and materials
Data sharing is not applicable to this article as no datasets were generated
or analyzed during the current study.
Authors’ contributions
MB, AR, ER, ED, and MM carried out the data collection and drafted the
manuscript. NC, FD, AS, and FC participated in the design of the study
and performed the statistical analysis. All authors read and approved the
final manuscript.
Ethics approval and consent to participate




The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Received: 27 July 2018 Accepted: 11 September 2018
References
1. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin
and C-reactive protein levels as markers of bacterial infection: a systematic
review and meta-analysis. Clin Infect Dis. 2004;39:206–17.
2. de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, et al.
Efficacy and safety of procalcitonin guidance in reducing the duration of
antibiotic treatment in critically ill patients: a randomised, controlled, open-
label trial. Lancet Infect Dis. 2016;16:819–27.
3. Oliveira CF, Botoni FA, Oliveira CR, Silva CB, Pereira HA, Serufo JC, et al.
Procalcitonin versus C-reactive protein for guiding antibiotic therapy in
sepsis: a randomized trial. Crit Care Med. 2013;41:2336–43.
4. Yan ST, Sun LC, Lian R, Tao YK, Zhang HB, Zhang G. Diagnostic and
predictive values of procalcitonin in bloodstream infections for nosocomial
pneumonia. J Crit Care. 2018;44:424–9.
5. Oussalah A, Ferrand J, Filhine-Tresarrieu P, Aissa N, Aimone-Gastin I, Namour
F, et al. Diagnostic Accuracy of Procalcitonin for Predicting Blood Culture
Results in Patients With Suspected Bloodstream Infection: An Observational
Study of 35,343 Consecutive Patients (A STROBE-Compliant Article).
Medicine (Baltimore). 2015;94:e1774.
Fig. 1 Procalcitonin (PCT) concentrations (in nanograms per milliliter) in patients with Gram-negative, Enterobacteriaceae, Gram-positive, and
fungal etiologies. Abbreviation: SD standard deviation
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